TrialDiabetes, obesity & metabolism2011
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*).
W Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
52 papers cite it
this paperpooled ittrialcites it